Fibrin clot properties in acute stroke: what differs cerebral hemorrhage from cerebral ischemia?

Stroke. 2012 May;43(5):1412-4. doi: 10.1161/STROKEAHA.111.646729. Epub 2012 Feb 16.

Abstract

Background and purpose: Fibrin clot formation is important in acute intracerebral hemorrhage (ICH). We investigated plasma fibrin clot characteristics in acute ICH compared with acute ischemic stroke (IS) and nonstroke conditions.

Methods: In the 3 studied groups, we analyzed plasma fibrin clot phenotype and its association with clinical stroke presentation.

Results: Compared with controls, in patients with acute strokes, fibrin clots presented with lower clot permeability, longer lysis time, and higher maximum clot absorbance (for all, P<0.001). In ICH patients compared with IS patients, only lysis time was shorter by 13% (P<0.001). In the ICH group, neurological deficit correlated significantly (P<0.05) with clot compaction, and the rate of increase in d-dimers released from clots, whereas initial hematoma volume correlated with lag phase of fibrin formation on turbidimetry and compaction (P<0.05).

Conclusions: In both types of acute strokes, fibrin clot properties are altered: denser fibrin clots are relatively resistant to lysis. In acute ICH, fibrin clots are more susceptible to tissue plasminogen activator-mediated lysis compared with in IS, which might affect ICH pathogenesis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cerebral Hemorrhage / drug therapy
  • Cerebral Hemorrhage / metabolism*
  • Cerebral Hemorrhage / pathology
  • Female
  • Fibrin / metabolism*
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Intracranial Thrombosis / metabolism*
  • Intracranial Thrombosis / pathology*
  • Male
  • Middle Aged
  • Phenotype
  • Stroke / drug therapy
  • Stroke / metabolism*
  • Stroke / pathology
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrin Fibrinogen Degradation Products
  • Fibrinolytic Agents
  • fibrin fragment D
  • Fibrin
  • Tissue Plasminogen Activator